SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Abivax SA posts Q1 loss wider than expected, revenue beats estimates

Abivax SA reported a quarterly adjusted loss of 61 cents per share for the quarter ended March 31, a wider loss than the -83 cents reported in the same quarter last year, and beating the mean expectation of five analysts for a loss of 100 cents per share. Revenue rose 20.8% to €994.00 thousand from a year ago, beating analyst expectations of €695.34 thousand.

ABVX.O

Abivax SA reported a quarterly adjusted loss of 61 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -83 cents. The mean expectation of five analysts for the quarter was for a loss of 100 cents per share. Wall Street expected results to range from -92 cents to -49 cents per share. Revenue rose 20.8% to €994.00 thousand from a year ago; analysts expected €695.34 thousand.

Abivax SA's reported EPS for the quarter was a loss of €1.47​. The company reported a quarterly loss of €48.5 million. Abivax SA shares had fallen by 21.2% this quarter and lost 22.1% so far this year.

Forecast Changes The mean earnings estimate of analysts had risen by about 17.2% in the last three months.​ In the last 30 days, there have been no negative revisions of earnings estimates Recommendations The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" Wall Street's median 12-month price target for Abivax SA is $156.50, about 32.9% above its last closing price of $105.04 This summary was machine generated from LSEG data September 21 at 09:46 p.m. UTC.

​All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET, MISSED Mar. 31 2026 -0.82 -0.61 Beat Mar.

31 2026 -1.25 -1.14 Beat Dec. 31 2025 -1.25 -2.10 Missed Jun. 30 2025 -0.67 -0.76 Missed

Related stories